Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Projects/Programs

Displaying 51 - 75 of 528

Cardiac Device Reliability

Ongoing
The growing sophistication of electronic medical devices results in two broad benefits for both individuals and society: improved survivability in the face of

Cell Counting for Cell Therapies

Ongoing
Cell counting (or cell enumeration) is one of the most fundamental measurements in biotechnology, from biomanufacturing to medical diagnosis to advanced therapy

Cell Line Authentication

Ongoing
Cells derived from different organisms and tissues have been established and are used in bioresearch and for the production of complex biological products. The

Cell Viability for Advanced Therapies

Ongoing
Cell viability is a fundamental measurement in the characterization of cells. Cell viability assays refer to a class of measurements that assess the health of a

Characterization of 3D Photovoltaics

Completed
Our goal is to provide industry with test structures and models of next-generation photovoltaics, with an initial focus on cadmium telluride (CdTe) and CuInxGa1

Charpy Machine Verification Program

Ongoing
WARNING RELATED TO TESTING SUPER-HIGH ENERGY SPECIMENS The steel currently used by NIST for the production of super-high energy reference Charpy specimens tends

CHiMaD Phase Field Community

Ongoing
CHiMaD Phase Field Website Repository See the live website at pages.nist.gov/chimad-phase-field. In January 2015 a group of phase field

Cloud of Reproducible Records

Ongoing
An important part of the NIST (National Institute of Science and Technology) MGI (Materials Genome Initiative) effort is to investigate infrastructure and tools

Combating Antibiotic Resistance

Ongoing
A Paradigm Shift in Addressing Antimicrobial Resistance: Measuring the Transition Between Antibiotic Susceptibility and Resistance With the exception of our own